Impact of a bronchiolitis guideline: A multisite demonstration project

Uma R. Kotagal, James M. Robbins, Narendra M. Kini, Pamela J. Schoettker, Harry D. Atherton, Mark S. Kirschbaum

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Study objectives: The purpose of this study was to determine the impact of a multisite implementation of an evidence-based clinical practice guideline for bronchiolitis. Design: Before and after study. Setting: Eleven Child Health Accountability Initiative (CHAI) study hospitals. Patients: Children < 12 months of age with a first-time episode of bronchiolitis. Intervention: The guideline was implemented in December 1998. Complete preimplementation and postimplementation administrative data on hospital admissions, resource utilization, and length of stay were available from seven study hospitals. At five sites, chart reviews were conducted for data on the number and type of bronchodilators used. Measurements and results: Complete administrative data were available for 846 historical control subjects and 792 study patients. Length of stay decreased significantly. While the proportion of eligible patients who received any bronchodilator did not change (84%), the proportion of patients who received albuterol decreased from 80 to 75% after guideline implementation (p < 0.03). For patients who received bronchodilators, the mean (± SD) number of doses decreased from 13.6 ± 14.0 to 7.3 ± 9.1 doses (p ± 0.0001). For patients who received albuterol, the mean number of doses decreased from 12.8 ± 11.8 to 6.4 ± 7.8 doses (p < 0.0001). Other resource use decreased modestly. Hospital readmission rates within 7 days of discharge were unchanged. Conclusions: We successfully extended the implementation of an evidence-based clinical practice guideline from one hospital to seven hospitals. Within just a single bronchiolitis season, some significant changes in practice were seen. The multisite CHAI collaborative appears to be a promising laboratory for large-scale quality improvement initiatives.

Original languageEnglish (US)
Pages (from-to)1789-1797
Number of pages9
JournalChest
Volume121
Issue number6
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Bronchiolitis
Guidelines
Bronchodilator Agents
Albuterol
Evidence-Based Practice
Social Responsibility
Practice Guidelines
Length of Stay
Patient Readmission
Quality Improvement

Keywords

  • Bronchiolitis
  • Guideline
  • Multi-site demonstration

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Kotagal, U. R., Robbins, J. M., Kini, N. M., Schoettker, P. J., Atherton, H. D., & Kirschbaum, M. S. (2002). Impact of a bronchiolitis guideline: A multisite demonstration project. Chest, 121(6), 1789-1797. https://doi.org/10.1378/chest.121.6.1789

Impact of a bronchiolitis guideline : A multisite demonstration project. / Kotagal, Uma R.; Robbins, James M.; Kini, Narendra M.; Schoettker, Pamela J.; Atherton, Harry D.; Kirschbaum, Mark S.

In: Chest, Vol. 121, No. 6, 2002, p. 1789-1797.

Research output: Contribution to journalArticle

Kotagal, UR, Robbins, JM, Kini, NM, Schoettker, PJ, Atherton, HD & Kirschbaum, MS 2002, 'Impact of a bronchiolitis guideline: A multisite demonstration project', Chest, vol. 121, no. 6, pp. 1789-1797. https://doi.org/10.1378/chest.121.6.1789
Kotagal UR, Robbins JM, Kini NM, Schoettker PJ, Atherton HD, Kirschbaum MS. Impact of a bronchiolitis guideline: A multisite demonstration project. Chest. 2002;121(6):1789-1797. https://doi.org/10.1378/chest.121.6.1789
Kotagal, Uma R. ; Robbins, James M. ; Kini, Narendra M. ; Schoettker, Pamela J. ; Atherton, Harry D. ; Kirschbaum, Mark S. / Impact of a bronchiolitis guideline : A multisite demonstration project. In: Chest. 2002 ; Vol. 121, No. 6. pp. 1789-1797.
@article{21c11c0768ae4a83bd43d67c7b4847c2,
title = "Impact of a bronchiolitis guideline: A multisite demonstration project",
abstract = "Study objectives: The purpose of this study was to determine the impact of a multisite implementation of an evidence-based clinical practice guideline for bronchiolitis. Design: Before and after study. Setting: Eleven Child Health Accountability Initiative (CHAI) study hospitals. Patients: Children < 12 months of age with a first-time episode of bronchiolitis. Intervention: The guideline was implemented in December 1998. Complete preimplementation and postimplementation administrative data on hospital admissions, resource utilization, and length of stay were available from seven study hospitals. At five sites, chart reviews were conducted for data on the number and type of bronchodilators used. Measurements and results: Complete administrative data were available for 846 historical control subjects and 792 study patients. Length of stay decreased significantly. While the proportion of eligible patients who received any bronchodilator did not change (84{\%}), the proportion of patients who received albuterol decreased from 80 to 75{\%} after guideline implementation (p < 0.03). For patients who received bronchodilators, the mean (± SD) number of doses decreased from 13.6 ± 14.0 to 7.3 ± 9.1 doses (p ± 0.0001). For patients who received albuterol, the mean number of doses decreased from 12.8 ± 11.8 to 6.4 ± 7.8 doses (p < 0.0001). Other resource use decreased modestly. Hospital readmission rates within 7 days of discharge were unchanged. Conclusions: We successfully extended the implementation of an evidence-based clinical practice guideline from one hospital to seven hospitals. Within just a single bronchiolitis season, some significant changes in practice were seen. The multisite CHAI collaborative appears to be a promising laboratory for large-scale quality improvement initiatives.",
keywords = "Bronchiolitis, Guideline, Multi-site demonstration",
author = "Kotagal, {Uma R.} and Robbins, {James M.} and Kini, {Narendra M.} and Schoettker, {Pamela J.} and Atherton, {Harry D.} and Kirschbaum, {Mark S.}",
year = "2002",
doi = "10.1378/chest.121.6.1789",
language = "English (US)",
volume = "121",
pages = "1789--1797",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Impact of a bronchiolitis guideline

T2 - A multisite demonstration project

AU - Kotagal, Uma R.

AU - Robbins, James M.

AU - Kini, Narendra M.

AU - Schoettker, Pamela J.

AU - Atherton, Harry D.

AU - Kirschbaum, Mark S.

PY - 2002

Y1 - 2002

N2 - Study objectives: The purpose of this study was to determine the impact of a multisite implementation of an evidence-based clinical practice guideline for bronchiolitis. Design: Before and after study. Setting: Eleven Child Health Accountability Initiative (CHAI) study hospitals. Patients: Children < 12 months of age with a first-time episode of bronchiolitis. Intervention: The guideline was implemented in December 1998. Complete preimplementation and postimplementation administrative data on hospital admissions, resource utilization, and length of stay were available from seven study hospitals. At five sites, chart reviews were conducted for data on the number and type of bronchodilators used. Measurements and results: Complete administrative data were available for 846 historical control subjects and 792 study patients. Length of stay decreased significantly. While the proportion of eligible patients who received any bronchodilator did not change (84%), the proportion of patients who received albuterol decreased from 80 to 75% after guideline implementation (p < 0.03). For patients who received bronchodilators, the mean (± SD) number of doses decreased from 13.6 ± 14.0 to 7.3 ± 9.1 doses (p ± 0.0001). For patients who received albuterol, the mean number of doses decreased from 12.8 ± 11.8 to 6.4 ± 7.8 doses (p < 0.0001). Other resource use decreased modestly. Hospital readmission rates within 7 days of discharge were unchanged. Conclusions: We successfully extended the implementation of an evidence-based clinical practice guideline from one hospital to seven hospitals. Within just a single bronchiolitis season, some significant changes in practice were seen. The multisite CHAI collaborative appears to be a promising laboratory for large-scale quality improvement initiatives.

AB - Study objectives: The purpose of this study was to determine the impact of a multisite implementation of an evidence-based clinical practice guideline for bronchiolitis. Design: Before and after study. Setting: Eleven Child Health Accountability Initiative (CHAI) study hospitals. Patients: Children < 12 months of age with a first-time episode of bronchiolitis. Intervention: The guideline was implemented in December 1998. Complete preimplementation and postimplementation administrative data on hospital admissions, resource utilization, and length of stay were available from seven study hospitals. At five sites, chart reviews were conducted for data on the number and type of bronchodilators used. Measurements and results: Complete administrative data were available for 846 historical control subjects and 792 study patients. Length of stay decreased significantly. While the proportion of eligible patients who received any bronchodilator did not change (84%), the proportion of patients who received albuterol decreased from 80 to 75% after guideline implementation (p < 0.03). For patients who received bronchodilators, the mean (± SD) number of doses decreased from 13.6 ± 14.0 to 7.3 ± 9.1 doses (p ± 0.0001). For patients who received albuterol, the mean number of doses decreased from 12.8 ± 11.8 to 6.4 ± 7.8 doses (p < 0.0001). Other resource use decreased modestly. Hospital readmission rates within 7 days of discharge were unchanged. Conclusions: We successfully extended the implementation of an evidence-based clinical practice guideline from one hospital to seven hospitals. Within just a single bronchiolitis season, some significant changes in practice were seen. The multisite CHAI collaborative appears to be a promising laboratory for large-scale quality improvement initiatives.

KW - Bronchiolitis

KW - Guideline

KW - Multi-site demonstration

UR - http://www.scopus.com/inward/record.url?scp=0036283383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036283383&partnerID=8YFLogxK

U2 - 10.1378/chest.121.6.1789

DO - 10.1378/chest.121.6.1789

M3 - Article

C2 - 12065340

AN - SCOPUS:0036283383

VL - 121

SP - 1789

EP - 1797

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -